Effect of Goal-Oriented Albumin Infusion on Postoperative Complication Management in Gastric Canc… (NCT07119463) | Clinical Trial Compass
RecruitingPhase 2
Effect of Goal-Oriented Albumin Infusion on Postoperative Complication Management in Gastric Cancer Surgery
China112 participantsStarted 2024-10-29
Plain-language summary
This study aims to evaluate the impact of goal-oriented albumin infusion on short-term postoperative outcomes in gastric cancer patients. It is a single-center, prospective, non-randomized controlled study. Patients are divided into two groups: the experimental group receives albumin infusion when serum albumin levels fall below 25 g/L, while the control group receives albumin infusion when levels fall below 30 g/L. The primary endpoint is the incidence of complications graded Clavien-Dindo III or above within 30 days post-surgery. Secondary endpoints include nutritional recovery, gastrointestinal function recovery, hospital stay duration, and overall complication rates. The study seeks to optimize perioperative albumin management strategies and improve clinical outcomes.
Who can participate
Age range18 Years – 80 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Age range: 18 to 80 years old, suitable for patients undergoing gastric cancer surgery.
✓. Gastric cancer diagnosis: gastric cancer patients confirmed by pathology, regardless of pathological type.
✓. Cancer staging: Patients with preoperative CT assessment of TNM stage I to III and undergoing laparoscopic gastric cancer surgery or open gastric cancer surgery can be included.
✓. Type of surgery: patients who undergo any radical gastric cancer surgery (no restriction on surgical type, covering partial gastrectomy, total gastrectomy, etc.).
✓. The patient gave informed consent to this study and signed the corresponding informed consent form.
✓. ASA classification I-III.
✓. ECOG score ≤ 2
Exclusion criteria
✕. Preoperative acute infection: Acute infection or acute complications (such as pneumonia, urinary tract infection, gastrointestinal bleeding, perforation, obstruction, etc.) have been diagnosed before surgery.
What they're measuring
1
Incidence of Postoperative Complications (Clavien-Dindo Grade III or Above)
✕. Immunosuppressed patients: such as long-term use of immunosuppressants (such as glucocorticoids), organ transplant patients, or those who have been diagnosed with HIV infection.
✕. Serious basic diseases: such as severe liver insufficiency (Child Pugh class B or C), renal insufficiency (serum creatinine\>133umol/L), severe cardiac insufficiency (NYHA class III and above), severe pulmonary insufficiency (preoperative blood gas analysis PaO2 ≤ 60mmHg).
✕. Patients with a history of albumin allergy.
✕. Intraoperative blood loss is greater than 500ml.
✕. Preoperative hemoglobin \<70g/L.
✕. Receive neoadjuvant radiotherapy before surgery.
✕. Patients who require combined organ resection.